NVCRNovoCure Limited
$14.58+15% 1Y
$14.58
$10.0352 weeks$20.00
Latest close: back above its 200-day averageOct 9, 2026what changed →
Is the price fair?
What NVCR's price assumes
NovoCure Limited did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2.50× revenue.
2.50
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 5.16
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 5.16
- EV / EBIToperating margin −22%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $1.74B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.